Acura Pharmaceuticals Partners With Egalet Corporation to Commercialize … – MarketWatch

PALATINE, IL, Jan 08, 2015 (Marketwired via COMTEX) — Acura Pharmaceuticals, Inc. ACUR, +0.00% today announced that the Company has entered into a Collaboration and License Agreement (the “Agreement”) with Egalet US, Inc. and Egalet Ltd. (together “Egalet”, subsidiaries of Egalet Corporation (NASDAQ: EGLT), which is also a party to the Agreement with obligations thereunder) granting Egalet exclusive worldwide rights to (more…)